OSCAR HEALTH INC - CLASS A (OSCR) Stock Analyst Ratings
NYSE:OSCR - US6877931096 - Common Stock
16.8499 USD
+0.05 (+0.3%)
ChartMill assigns a Buy % Consensus number of 50% to OSCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.64. This target is -24.97% below the current price.
OSCR was analyzed by 16 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about OSCR.
In the last month the buy percentage fell by 23 points. So the trust of analysts is decreasing.
OSCR was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-25 | Baird | Downgrade | Outperform -> Neutral |
| 2025-07-23 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-15 | UBS | Downgrade | Neutral -> Sell |
| 2025-07-11 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2025-07-02 | Barclays | Initiate | Underweight |
| 2025-06-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-13 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-10 | Jefferies | Initiate | Underperform |
| 2024-11-06 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-10-07 | UBS | Initiate | Neutral |
| 2024-09-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-26 | Piper Sandler | Initiate | Overweight |
| 2024-06-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-30 | Baird | Initiate | Outperform |
| 2024-05-30 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-05-20 | B of A Securities | Maintains | Buy -> Buy |
| 2024-05-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-22 | Raymond James | Initiate | Outperform |
| 2024-02-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-08-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-09 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-07-14 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-13 | Wells Fargo | Maintains | Overweight |